ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance (2014)
- Authors:
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; COVAS, DIMAS TADEU - FMRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1016/j.bcmd.2014.02.008
- Subjects: LEUCEMIA MIELOIDE AGUDA; APOPTOSE; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Publisher place: Maryland Heights
- Date published: 2014
- Source:
- Título do periódico: Blood Cells, Molecules and Diseases
- ISSN: 1079-9796
- Volume/Número/Paginação/Ano: v. 53, n. 1-2, p. 47-55, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FERREIRA, A. F. et al. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, v. 53, n. 1-2, p. 47-55, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2014.02.008. Acesso em: 28 mar. 2024. -
APA
Ferreira, A. F., Moura, L. G., Tojal, I., Ambrósio, L., Simões, B. P., Hamerschlak, N., et al. (2014). ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, 53( 1-2), 47-55. doi:10.1016/j.bcmd.2014.02.008 -
NLM
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008 -
Vancouver
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008 - The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms
- Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia
- PRV-1 overexpression in essential thrombocythemia correlates with trail expression
- Apoptomirs expression profile in polycythemia vera patients
- Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]
- Avaliação do perfil de resistência dos lifócitos de pacientes com trombocitemia essencial aos agentes apoptogênicos
- Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients
- Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis
- Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
- Menchymal stromal cells in the treatment of grade III-IV steroid-resistant GVHD
Informações sobre o DOI: 10.1016/j.bcmd.2014.02.008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas